Beddingfield III Frederick 4
4 · Sienna Biopharmaceuticals, Inc. · Filed May 21, 2018
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Other
Common Stock
2018-05-17+47,594→ 601,246 total
Holdings
- 14,076(indirect: See Footnote)
Common Stock
- 14,076(indirect: See Footnote)
Common Stock
- 112,614(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Dr. Beddingfield acquired the shares pursuant to a mandatory distribution from Venvest Biotech, LLC ("Venvest") for which Dr. Beddingfield has a previously disclosed economic interest in any gain associated with the shares of the Issuer's capital stock purchased by Venvest in the Issuer's Series A-3 and Series B Preferred Stock financings. Dr. Beddingfield has no management or voting rights in respect of Venvest (Including no voting or investment power with respect to shares of the Issuer's capital stock held by Venvest).
- [F2]The shares are directly held by Beddingfield Children's Trust fbo Catherine Sara Beddingfield.
- [F3]The shares are directly held by Beddingfield Children's Trust fbo Claire Elizabeth Beddingfield.
- [F4]The shares are directly held by the Beddingfield Family Trust.